Menu
News
Ibogaine
Ketamine
LSD
MDMA
Psilocybin
Resources
Research Hubs
Studies and Reports
Provider Directory
Terminology
Opinion
Events
About Us
Lykos Therapeutics
Lykos Therapeutics Shakeup Continues With Leadership Change
September
6
,
2024
Analysis: MDMA Setback Shows Psychedelic Medicine Still Has Work Ahead
June
7
,
2024
Lykos Appoints Finance Veteran Scott Giacobello to Board of Directors
May
31
,
2024
Concerns Raised About MDMA-Assisted Psychotherapy Trials for PTSD
May
17
,
2024
Lykos Therapeutics: FDA Set to Review MDMA for PTSD Treatment
May
9
,
2024